Client Spotlight Alnylam, Skyland Analytics

BACKGROUND

Alnylam is the world’s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.

REQUIREMENTS FULFILLED BY SKYLAND PIMS®

  • Data sharing among internal teams and CMOs
  • Lower risk compared to reliance on in-house database
  • FDA validatable environment
  • End-to-end manufacturing and quality data platform across 2 commercial products and 6 clinical stage products
  • 21 CFR Part II compliant
  • Centralized, higher data integrity platform
  • Use of PIMS with other analytics tools e.g. JMP
  • Compatible with current and future automation payments
  • Higher efficiencies through automated work processes
  • Reduced risk of non-compliance
  • Knowledge sharing across complete portfolio of clinical and commercial products